M&A Deal Summary

Avita Acquires PharmBlue

On June 8, 2020, Avita acquired life science company PharmBlue

Acquisition Highlights
  • This is Avita’s 3rd transaction in the Life Science sector.
  • This is Avita’s 4th transaction in the United States.
  • This is Avita’s 1st transaction in Pennsylvania.

M&A Deal Summary

Date 2020-06-08
Target PharmBlue
Sector Life Science
Buyer(s) Avita
Deal Type Merger

Target

PharmBlue

Warrendale, Pennsylvania, United States
PharmBlue is a provider of pharmacy solutions primarily for Covered Entities throughout the Midwest. PharmBlue was formed in 2012 and is based in Warrendale, Pennsylvania.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Avita

Baton Rouge, Louisiana, United States

Category Company
Founded 2003
Sector Life Science
DESCRIPTION

Avita is a specialized pharmacy which dispenses and delivers prescription medications for patients with certain chronic diseases. Avita also provides extensive patient data to the caregivers, prescribing physicians and community based organizations to assist with monitoring patient adherence. Avita was founded in 2003 and is based in Baton Rouge, Louisiana.


DEAL STATS #
Overall 4 of 6
Sector: Life Science M&A 3 of 4
Type: Merger M&A Deals 2 of 2
State: Pennsylvania M&A 1 of 1
Country: United States M&A 4 of 6
Year: 2020 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-08 Paramount

Melville, New York, United States

Paramount is a provider of pharmacy solutions primarily for Covered Entities throughout New York. Paramount Specialty Pharmacy is based in Melville, New York.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-02-03 Advantage Healthcare Services - Two HIV-Focused Pharmacies

Garden Grove, California, United States

Two California HIV-Focused Pharmacies serve over 5,000 patients and nearly 2,000 HIV lives across 300+ provider network locations and nine Covered Entity partners.

Buy -